Cite

1. FATOURECHI V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009; 84(1):65-71.10.4065/84.1.65Search in Google Scholar

2. WIERSINGA WM. Guidance in subclinical hyperthyroidism and subclinical hypothyroidism: are we making progress? Eur Thyroid J. 2015; 4(3):143-8.10.1159/000438909463750926558231Search in Google Scholar

3. MALEKI N., KAZEROUNI F., HEDAYATI M., RAHIMIPOUR A., PARHAM M. Subclinical hypothyroidism and the alterations of lipid profile as a cardiovascular risk factor. J Paramed Sci. 2015; 6(4):2008-4978.Search in Google Scholar

4. RIZOS CV., ELISAF MS., LIBEROPOULUS EN. Effects of thyroid dysfunction on lipid profile, Open Cardiovasc Med J. 2011; 5:76-84.Search in Google Scholar

5. VANDERMEERSCH A., AMEYE S., PUYPE D., PETITJEAN D., De BUYZERE M., LANGLOIS MR. Estimation of the lowdensity lipoprotein (LDL) subclass phenotype using a direct, automated assay of small dense LDL-cholesterol without sample pretreatment. Clin Chim Acta. 2010; 411(17-18):1361-66.10.1016/j.cca.2010.05.03820561981Search in Google Scholar

6. NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP) EXPERT PANEL ON DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS (Adult Treatment Panel III), Third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002; 106(25):3143-3421.10.1161/circ.106.25.3143Search in Google Scholar

7. AUSTIN MA., BRESLOW JL., HENNEKENS CH., BURING JE., WILLETT WC., KRAUSS RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988; 260(13):1917-21.10.1001/jama.1988.03410130125037Search in Google Scholar

8. CARMENA R., DURIEZ P., FRUCHART JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004; 109 (23 Suppl 1):III2-7.10.1161/01.CIR.0000131511.50734.4415198959Search in Google Scholar

9. BERNEIS KK., KRAUSSS RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002; 43(9):1363-79.10.1194/jlr.R200004-JLR20012235168Search in Google Scholar

10. LAMARCHE B., TCHERNOF A., MOORJANI S., CANTIN B., DAGENAIS GR., LUPIEN PJ., et al. Small, dense LDL particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 1997; 95(1):69-75.10.1161/01.CIR.95.1.698994419Search in Google Scholar

11. VERHOYE E., LANGLOIS MR., ASKLEPIOS INVESTIGATORS. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab Med. 2009; 47(2):128-37.10.1515/CCLM.2009.03719099526Search in Google Scholar

12. TOGNINI S., POLINI A., PASAQUALETTI G., URSINO S., CARACCIO N., ERDEGHINI M., et al. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study. Thyroid. 2012; 22(11):1096-103.10.1089/thy.2012.001323050788Search in Google Scholar

13. HAK AE., POLS HA., VISSER TJ., DREXHAGE HA., HOFMAN A., WITTEMAN JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000; 132(4):270-8.10.7326/0003-4819-132-4-200002150-0000410681281Search in Google Scholar

14. WALSH JP., BREMNER AP., BULSARA MK., O’LEARY P., LEEDMAN PJ., FEDDEMA P., et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005; 165(21):2467-72.10.1001/archinte.165.21.246716314542Search in Google Scholar

15. COOPER DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001; 345(4):260-5.10.1056/NEJM20010726345040611474665Search in Google Scholar

16. KLEIN I. Subclinical hypothyroidism - just a high serum thyrotropin concentration or something else? J Clin Endocrinol Metab. 2013; 98(2):508-10.10.1210/jc.2012-408823390261Search in Google Scholar

17. DUNTAS LH., BRENTA G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am. 2012; 96(2):269-81.10.1016/j.mcna.2012.01.01222443975Search in Google Scholar

18. PEARCE EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab. 2012; 97(2):326-33.10.1210/jc.2011-253222205712Search in Google Scholar

19. BOEKHOLDT SM., TITAN SM., WIERSINGA WM., CHATTERJEE K., BASART DC., LUBEN R., et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010; 72(3):404-10.10.1111/j.1365-2265.2009.03640.x19486022Search in Google Scholar

20. WORLD HEALTH ORGANIZATION. “BMI Classification”. Global Database on Body Mass Index. 2006.Search in Google Scholar

21. KUSIC Z., JUKIC T., FRANCESCHI M., DEBELIC N., RONCEVIC S., LUKINAC L. Croatian Thyroid Society guidelines for rational detection of thyroid dysfunction. Lijec Vjesn. 2009; 131(11-12):328-38.Search in Google Scholar

22. LUBOSHITZKY R., AVIV A., HERER P., LAVIE L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid. 2002; 12(5):421-5.10.1089/10507250276004351212097204Search in Google Scholar

23. KARTHICK N., DILLARA K., POORNIMA KN., SBHASINI AS. Dyslipidaemic changes in women with subclinical hypothyroidism. J Clin Diagn Res. 2013; 7(10):2122-5.10.7860/JCDR/2013/5777.3448384338924298454Search in Google Scholar

24. TOURNER F., ALTINOVA AE., KARAKOC A., YETKIN I., AYVAZ G., CAKIR N., et al. Risk factors for cardiovascular disease in patients with subclinical hypothyroidism. Adv Ther. 2008; 25(5):430-7.10.1007/s12325-008-0053-718484201Search in Google Scholar

25. PEARCE SH., BRABANT G., DUNTAS LH., MONZANI F., PEETERS RP., RAZVI S., et al. 2013 ETA Guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013; 2(4):215-28.10.1159/000356507392360124783053Search in Google Scholar

26. ABBAS JM., CHAKRABORTY J., AKANJI AO., DOI SA. Hypothyroidism results in small dense LDL independent of IRS traits and hypertriglyceridemia. Endocr J. 2008; 55(2):381-9.10.1507/endocrj.K07E-06518385530Search in Google Scholar

27. RAZVI S., WEAVER JU., VANDERPUMP MP, PEARCE SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: re-analysis of the Whickham Survey cohort. J Clin Endocrinol Metab 2010; 95:1734-40.10.1210/jc.2009-174920150579Search in Google Scholar

28. CAPPOLA AR., FRIED LP., ARNOLD AM., DANESE MD., KULLER LH., BURKE GL., et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006; 295(9):1033-41.10.1001/jama.295.9.1033138782216507804Search in Google Scholar

29. LAM KS., CHAN MK., YEUNG RT. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction-effects of treatment. Q J Med. 1986; 59(229):513-521.Search in Google Scholar

30. PEARCE EN., WILSON PW., YANG Q., VASAN RS., BRAVERMAN LE. Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort. J Clin Endocrinol Metab. 2008; 93(3):888-94.10.1210/jc.2007-1987226694618073305Search in Google Scholar

eISSN:
2501-062X
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, other, Cardiology, Gastroenterology, Rheumatology